Donald L Trump


Ontology type: schema:Person     


Person Info

NAME

Donald L

SURNAME

Trump

Publications in SciGraph latest 50 shown

  • 2016-12 Pitfalls of improperly procured adjacent non-neoplastic tissue for somatic mutation analysis using next-generation sequencing in BMC MEDICAL GENOMICS
  • 2013-08 Serum Vitamin D Metabolites in Colorectal Cancer Patients Receiving Cholecalciferol Supplementation: Correlation with Polymorphisms in the Vitamin D Genes in HORMONES AND CANCER
  • 2013-05 A phase I/II pharmacokinetic and pharmacogenomic study of calcitriol in combination with cisplatin and docetaxel in advanced non-small-cell lung cancer in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2012-04 Variants in the vitamin D pathway, serum levels of vitamin D, and estrogen receptor negative breast cancer among African-American women: a case-control study in BREAST CANCER RESEARCH
  • 2012 Variants in the vitamin D pathway, serum levels of vitamin D, and estrogen receptor negative breast cancer among African-American women: a case-control study in BREAST CANCER RESEARCH
  • 2011-12 A phase I study of the vitamin D3 analogue ILX23-7553 administered orally to patients with advanced solid tumors in INVESTIGATIONAL NEW DRUGS
  • 2011-05 The effect of various vitamin D supplementation regimens in breast cancer patients in BREAST CANCER RESEARCH AND TREATMENT
  • 2011-01 Serological immune responses to influenza vaccine in patients with colorectal cancer in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2011-01 Oral bioavailability of DN101, a concentrated formulation of calcitriol, in tumor-bearing dogs in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2010-10-29 Vitamin D and Angiogenesis in VITAMIN D AND CANCER
  • 2009-12 A phase I and pharmacokinetics study of intravenous calcitriol in combination with oral dexamethasone and gefitinib in patients with advanced solid tumors in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2009-02 Chemotherapy is linked to severe vitamin D deficiency in patients with colorectal cancer in INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
  • 2008-12 A dramatic, objective antiandrogen withdrawal response: case report and review of the literature in JOURNAL OF HEMATOLOGY & ONCOLOGY
  • 2008-10 In vitro and in vivo evaluation of combined calcitriol and cisplatin in dogs with spontaneously occurring tumors in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2007-12 Docetaxel-induced Meibomian duct inflammation and blockage leading to chalazion formation in PROSTATE CANCER AND PROSTATIC DISEASES
  • 2007-09 Vitamin D signalling pathways in cancer: potential for anticancer therapeutics in NATURE REVIEWS CANCER
  • 2007-04 Phase I study of weekly DN-101, a new formulation of calcitriol, in patients with cancer in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2007-01 Monocyte fructose 1,6-bisphosphatase and cytidine deaminase enzyme activities: potential pharmacodynamic measures of calcitriol effects in cancer patients in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2006-04 Phase I and pharmacokinetic study of the novel redox-active agent, motexafin gadolinium, with concurrent radiation therapy in patients with locally advanced pancreatic or biliary cancers in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2005-11 Pharmacokinetics of liquid calcitriol formulation in advanced solid tumor patients: comparison with caplet formulation in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2005-03 Population pharmacokinetic analysis of 17-(allylamino)-17-demethoxygeldanamycin (17AAG) in adult patients with advanced malignancies in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2004-12 Pharmacokinetic studies of 9-nitrocamptothecin on intermittent and continuous schedules of administration in patients with solid tumors in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2004-07 Diallyl trisulfide-induced apoptosis in human prostate cancer cells involves c-Jun N-terminal kinase and extracellular-signal regulated kinase-mediated phosphorylation of Bcl-2 in ONCOGENE
  • 2003-06 Phase III study of combined chemohormonal therapy in metastatic prostate cancer (ECOG 3882) in MEDICAL ONCOLOGY
  • 2003-05 Chemotherapy of prostate cancer: Present and future in CURRENT UROLOGY REPORTS
  • 2003 Prostate Cancer in GERIATRIC MEDICINE
  • 2002-12 Pharmacokinetics of high‐dose oral calcitriol: Results from a phase 1 trial of calcitriol and paclitaxel in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • 2002-12 Decreased tumor blood flow as measured by positron emission tomography in cancer patients treated with interleukin-1 and carboplatin on a phase I trial in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2002-09 Phase I and pharmacokinetic study of vinblastine and high-dose megestrol acetate in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2002-06 Vitamin D-related Therapies in Prostate Cancer in CANCER AND METASTASIS REVIEWS
  • 2002 Vitamin D-related therapies in prostate cancer in PROSTATE CANCER: NEW HORIZONS IN RESEARCH AND TREATMENT
  • 2001-12 TNF-α protects dendritic cells from prostate cancer-induced apoptosis in PROSTATE CANCER AND PROSTATIC DISEASES
  • 2001-02 Toxicity and Response Evaluation of the Interferon Inducer Poly ICLC Administered at Low Dose in Advanced Renal Carcinoma and Relapsed or Refractory Lymphoma: A Report of Two Clinical Trials of the Eastern Cooperative Oncology Group in INVESTIGATIONAL NEW DRUGS
  • 1999-10 A phase II trial of CI-958 in patients with hormone-refractory prostate cancer in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 1997-11 All-trans-retinoic acid modulation of drug-metabolizing enzyme activities: investigation with selective metabolic drug probes in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 1997-08 Interleukin-1α synergistic in vivo enhancement of cyclophosphamide- and carboplatin-mediated antitumor activity in CANCER IMMUNOLOGY, IMMUNOTHERAPY
  • 1997-01 A phase II trial of all-trans-retinoic acid in hormone-refractory prostate cancer: a clinical trial with detailed pharmacokinetic analysis in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 1996-12 A phase II trial of amonafide, caracemide, and homoharringtonine in the treatment of patients with advanced renal cell cancer in INVESTIGATIONAL NEW DRUGS
  • 1995-11 Phase I/II dose-escalation study of liarozole in patients with stage D, hormone-refractory carcinoma of the prostate in ANNALS OF SURGICAL ONCOLOGY
  • 1995-09 A phase II study of interleukin-2 with and without beta-interferon in the treatment of advanced renal cell carcinoma in INVESTIGATIONAL NEW DRUGS
  • 1995-06 Spinal cord compression in prostate cancer in JOURNAL OF NEURO-ONCOLOGY
  • 1995-01 A phase I trial of high-dose oral tamoxifen and CHOPE in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 1995-01 Population pharmacokinetics of hydroxyurea in cancer patients in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 1994-12 Phase II evaluation of the AMAP, 773U82 mesylate, in pancreatic cancer in INVESTIGATIONAL NEW DRUGS
  • 1994-09 Trimetrexate in advanced hormone-refractory prostate cancer in INVESTIGATIONAL NEW DRUGS
  • 1994-07 Pharmacokinetic and biotransformation studies of ormaplatin in conjunction with a phase I clinical trial in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 1994-06 Phase II study of echinomycin in the treatment of renal cell carcinoma ECOG study E2885 in INVESTIGATIONAL NEW DRUGS
  • 1993-09 Phase II trial and pharmacokinetic assessment of intravenous melphalan in patients with advanced prostate cancer in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 1993-06 5-Azacytidine (NSC 102816) in refractory germ cell tumors in INVESTIGATIONAL NEW DRUGS
  • 1993-03 A phase I trial of high-dose continuous-infusion hydroxyurea in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "https://www.grid.ac/institutes/grid.414629.c", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.240614.5", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.48336.3a", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.478063.e", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.430503.1", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.240684.c", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.14003.36", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.16753.36", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.21925.3d", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.32224.35", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.273335.3", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.417123.2", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.21107.35", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.257413.6", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.65499.37", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.26009.3d", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.412639.b", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.189509.c", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.254444.7", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.411935.b", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.416958.7", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.240283.f", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.251993.5", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.66875.3a", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.412647.2", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.214458.e", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.412530.1", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.414179.e", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.413734.6", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.413636.5", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.412750.5", 
            "type": "Organization"
          }
        ], 
        "familyName": "Trump", 
        "givenName": "Donald L", 
        "id": "sg:person.0710021450.77", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0710021450.77"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2019-03-07T15:02", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-researchers-20181010/20181011/dim_researchers/base/researchers_729.json", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.0710021450.77'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.0710021450.77'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.0710021450.77'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.0710021450.77'


     

    This table displays all metadata directly associated to this object as RDF triples.

    76 TRIPLES      10 PREDICATES      41 URIs      7 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:person.0710021450.77 schema:affiliation N1bbb8ea5cc404bbabdee7f591c74dec6
    2 https://www.grid.ac/institutes/grid.14003.36
    3 https://www.grid.ac/institutes/grid.16753.36
    4 https://www.grid.ac/institutes/grid.189509.c
    5 https://www.grid.ac/institutes/grid.21107.35
    6 https://www.grid.ac/institutes/grid.214458.e
    7 https://www.grid.ac/institutes/grid.21925.3d
    8 https://www.grid.ac/institutes/grid.240283.f
    9 https://www.grid.ac/institutes/grid.240614.5
    10 https://www.grid.ac/institutes/grid.240684.c
    11 https://www.grid.ac/institutes/grid.251993.5
    12 https://www.grid.ac/institutes/grid.254444.7
    13 https://www.grid.ac/institutes/grid.257413.6
    14 https://www.grid.ac/institutes/grid.26009.3d
    15 https://www.grid.ac/institutes/grid.273335.3
    16 https://www.grid.ac/institutes/grid.32224.35
    17 https://www.grid.ac/institutes/grid.411935.b
    18 https://www.grid.ac/institutes/grid.412530.1
    19 https://www.grid.ac/institutes/grid.412639.b
    20 https://www.grid.ac/institutes/grid.412647.2
    21 https://www.grid.ac/institutes/grid.412750.5
    22 https://www.grid.ac/institutes/grid.413636.5
    23 https://www.grid.ac/institutes/grid.413734.6
    24 https://www.grid.ac/institutes/grid.414179.e
    25 https://www.grid.ac/institutes/grid.416958.7
    26 https://www.grid.ac/institutes/grid.417123.2
    27 https://www.grid.ac/institutes/grid.430503.1
    28 https://www.grid.ac/institutes/grid.478063.e
    29 https://www.grid.ac/institutes/grid.48336.3a
    30 https://www.grid.ac/institutes/grid.65499.37
    31 https://www.grid.ac/institutes/grid.66875.3a
    32 schema:familyName Trump
    33 schema:givenName Donald L
    34 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0710021450.77
    35 schema:sdDatePublished 2019-03-07T15:02
    36 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    37 schema:sdPublisher N70175c2dd1fa46b5b94dd4cf6498dca1
    38 sgo:license sg:explorer/license/
    39 sgo:sdDataset persons
    40 rdf:type schema:Person
    41 N1bbb8ea5cc404bbabdee7f591c74dec6 schema:affiliation https://www.grid.ac/institutes/grid.414629.c
    42 sgo:isCurrent true
    43 rdf:type schema:OrganizationRole
    44 N70175c2dd1fa46b5b94dd4cf6498dca1 schema:name Springer Nature - SN SciGraph project
    45 rdf:type schema:Organization
    46 https://www.grid.ac/institutes/grid.14003.36 schema:Organization
    47 https://www.grid.ac/institutes/grid.16753.36 schema:Organization
    48 https://www.grid.ac/institutes/grid.189509.c schema:Organization
    49 https://www.grid.ac/institutes/grid.21107.35 schema:Organization
    50 https://www.grid.ac/institutes/grid.214458.e schema:Organization
    51 https://www.grid.ac/institutes/grid.21925.3d schema:Organization
    52 https://www.grid.ac/institutes/grid.240283.f schema:Organization
    53 https://www.grid.ac/institutes/grid.240614.5 schema:Organization
    54 https://www.grid.ac/institutes/grid.240684.c schema:Organization
    55 https://www.grid.ac/institutes/grid.251993.5 schema:Organization
    56 https://www.grid.ac/institutes/grid.254444.7 schema:Organization
    57 https://www.grid.ac/institutes/grid.257413.6 schema:Organization
    58 https://www.grid.ac/institutes/grid.26009.3d schema:Organization
    59 https://www.grid.ac/institutes/grid.273335.3 schema:Organization
    60 https://www.grid.ac/institutes/grid.32224.35 schema:Organization
    61 https://www.grid.ac/institutes/grid.411935.b schema:Organization
    62 https://www.grid.ac/institutes/grid.412530.1 schema:Organization
    63 https://www.grid.ac/institutes/grid.412639.b schema:Organization
    64 https://www.grid.ac/institutes/grid.412647.2 schema:Organization
    65 https://www.grid.ac/institutes/grid.412750.5 schema:Organization
    66 https://www.grid.ac/institutes/grid.413636.5 schema:Organization
    67 https://www.grid.ac/institutes/grid.413734.6 schema:Organization
    68 https://www.grid.ac/institutes/grid.414179.e schema:Organization
    69 https://www.grid.ac/institutes/grid.414629.c schema:Organization
    70 https://www.grid.ac/institutes/grid.416958.7 schema:Organization
    71 https://www.grid.ac/institutes/grid.417123.2 schema:Organization
    72 https://www.grid.ac/institutes/grid.430503.1 schema:Organization
    73 https://www.grid.ac/institutes/grid.478063.e schema:Organization
    74 https://www.grid.ac/institutes/grid.48336.3a schema:Organization
    75 https://www.grid.ac/institutes/grid.65499.37 schema:Organization
    76 https://www.grid.ac/institutes/grid.66875.3a schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...